These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 15995530)

  • 1. Is oxymetazoline really safe for middle ear use.
    Seidman MD
    Laryngoscope; 2005 Jul; 115(7):1321-3; author reply 1323. PubMed ID: 15995530
    [No Abstract]   [Full Text] [Related]  

  • 2. Oxymetazoline solutions inhibit middle ear pathogens and are not ototoxic.
    Isaacson G; Buttaro BA; Mazeffa V; Li G; Frenz DA
    Ann Otol Rhinol Laryngol; 2005 Aug; 114(8):645-51. PubMed ID: 16190099
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Rhinitis medicamentosa, an increasing problem. Do nose drops adversely affect bacterial infections?].
    Wilhelmson B
    Lakartidningen; 1994 Dec; 91(49):4635-6. PubMed ID: 7808178
    [No Abstract]   [Full Text] [Related]  

  • 4. Role of Topical Oxymetazoline for Management of Erythematotelangiectatic Rosacea.
    Hoover RM; Erramouspe J
    Ann Pharmacother; 2018 Mar; 52(3):263-267. PubMed ID: 29094614
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In Vitro Safety Pharmacology Profiling of Topical α-Adrenergic Agonist Treatments for Erythema of Rosacea.
    Piwnica D; Pathak A; Schäfer G; Docherty JR
    Drugs R D; 2018 Mar; 18(1):87-90. PubMed ID: 29374829
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Nasal decongestants and eye drops: keep out of children's reach!].
    Poulin-Chartrand S
    Perspect Infirm; 2013; 10(2):63. PubMed ID: 23539872
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of anticholinergics to treat bradycardia caused by alpha1-adrenergic agonist overdose is not safe.
    Sprung J; Alhaddad ST
    J Clin Anesth; 1996 Aug; 8(5):426-7. PubMed ID: 8832455
    [No Abstract]   [Full Text] [Related]  

  • 8. Topical oxymetazoline hydrochloride 0.05% as a strategy to reduce intraoperative wound oozing in Mohs micrographic surgery.
    Phillips CB; Huang CC
    Dermatol Surg; 2015 Jun; 41(6):749-50. PubMed ID: 25984903
    [No Abstract]   [Full Text] [Related]  

  • 9. Topical application of mitomycin C to the middle ear is ototoxic in the gerbil.
    Moody MW; Lang H; Spiess AC; Smythe N; Lambert PR; Schmiedt RA
    Otol Neurotol; 2006 Dec; 27(8):1186-92. PubMed ID: 16788424
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful treatment of the face post acne erythema using a topically applied selective alpha 1-Adrenergic receptor agonist, oxymetazoline 1.5%, a controlled left to right face comparative trial.
    Agamia N; Essawy M; Kassem A
    J Dermatolog Treat; 2022 Mar; 33(2):904-909. PubMed ID: 32602755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intranasal 3% Tetracaine Plus 0.05% Oxymetazoline in the Management of Status Migrainosus.
    Darsey M; Kyros T; Wang V; Rizzoli PB
    Headache; 2020 Feb; 60(2):471-472. PubMed ID: 31919839
    [No Abstract]   [Full Text] [Related]  

  • 12. Oxymetazoline Hydrochloride 1% Cream (Rhofade) for Persistent Facial Erythema Associated with Rosacea.
    Garcia C; Birch M
    Am Fam Physician; 2018 Jun; 97(12):808-810. PubMed ID: 30216014
    [No Abstract]   [Full Text] [Related]  

  • 13. Hemodynamic and pharmacokinetic analysis of oxymetazoline use during nasal surgery in children.
    Cartabuke RS; Anderson BJ; Elmaraghy C; Rice J; Tumin D; Tobias JD
    Laryngoscope; 2019 Dec; 129(12):2775-2781. PubMed ID: 30786035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Daily oxymetazoline cream demonstrates high and sustained efficacy in patients with persistent erythema of rosacea through 52 weeks of treatment.
    Gold MH; Lebwohl M; Biesman BS; Robinson DM; Luo L; Berk DR; Ahluwalia G; Alvandi N
    J Am Acad Dermatol; 2018 Sep; 79(3):e57-e59. PubMed ID: 29860043
    [No Abstract]   [Full Text] [Related]  

  • 15. Thunderclap headache and reversible segmental cerebral vasoconstriction associated with use of oxymetazoline nasal spray.
    Loewen AH; Hudon ME; Hill MD
    CMAJ; 2004 Sep; 171(6):593-4. PubMed ID: 15367461
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain-derived nerve growth factor in the treatment of sensorineural hearing loss.
    Meen E; Blakley B; Quddusi T
    Laryngoscope; 2009 Aug; 119(8):1590-3. PubMed ID: 19479743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Imaging of hearing loss.
    St Martin MB; Hirsch BE
    Otolaryngol Clin North Am; 2008 Feb; 41(1):157-78, vi-vii. PubMed ID: 18261530
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Histochemical studies on the ototoxicity of streptomycin].
    Müsebeck K
    Ann Univ Sarav Med; 1964; 11(3):159-270. PubMed ID: 5827417
    [No Abstract]   [Full Text] [Related]  

  • 19. Long-term hearing loss in gerbils with bacterial meningitis treated with superoxide dismutase.
    Ge NN; Brodie HA; Tinling SP
    Otol Neurotol; 2008 Dec; 29(8):1061-7. PubMed ID: 18849884
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of systemic and topical agents implicated in toxicity of the middle and inner ear.
    Roland PS
    Ear Nose Throat J; 2003 Jan; 82 Suppl 1():3-8. PubMed ID: 12610886
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.